|
CN111825609A
|
|
Compound crystal form, preparation method, pharmaceutical composition and application thereof
|
|
SG11201903463PA
|
|
Quinolyl-substituted carboxylic acid compound or pharmaceutically acceptable salt thereof, pharmaceutical composition of the same, and use of the same
|
|
CN108066335A
|
|
A kind of pharmaceutical composition containing taxol or its analog and preparation method thereof
|
|
CN107793382A
|
|
Novel crystal forms of anticancer compound CX1409 dihydrates and DMSO solvates and preparation method and application
|
|
CN107778271A
|
|
Anticancer compound CX1409 synthetic method
|
|
CN107540638A
|
|
Anticancer compound CX1409 novel crystal forms and preparation method and application
|
|
CN106556664A
|
|
A kind of method of separating and assaying of bortezomib and its optical isomer
|
|
CN106699699A
|
|
Trifluoro isopropyl-substituted taxol derivatives, and applications thereof
|
|
CN106290600A
|
|
A kind of liquid chromatography separation health Buddhist nun replaces Buddhist nun and the method having related substance
|
|
CN105232476A
|
|
Nolatrexed dihydrochloride freeze-dried powder injection, and preparation method thereof
|
|
CN105092752A
|
|
Method for separating nolatrexed dihydrochloride and related substances by liquid chromatography
|
|
CN104606284A
|
|
New uses of Ajuga ciliata Bunge extract
|
|
CN106892899A
|
|
A kind of nolatrexed dihydrochloride crystal formation III and preparation method and application
|
|
WO2014075374A1
|
|
Agkistrodon acutus hemocoagulase-b
|
|
CN103901146A
|
|
Measuring method of the content of acetylharpagide in blood
|
|
SG11201400769PA
|
|
Quinolyl-containing Hydroxamic Acid Compound and Preparation Method Thereof, and Pharmaceutical Composition Containing This Compound and Use Thereof
|
|
AU2011357483A1
|
|
Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application
|
